, Tracking Stock Market Picks
Enter Symbol:
Eclipsys Corporation (ECLP) [hlAlert]

down 9.21 %

Eclipsys Corporation (ECLP) upgraded to Buy with price target $24 by Auriga U.S.A

Posted on: Wednesday,  Sep 23, 2009  8:25 AM ET by Auriga U.S.A

Auriga U.S.A rated Buy Eclipsys Corporation (NASDAQ: ECLP) on 09/23/2009, when the stock price was $20.40. Since
then, Eclipsys Corporation has lost 9.22% as of 08/24/2010's recent price of $18.52.
If you would have followed this Auriga U.S.A's recommendation on ECLP, you would have lost 9.21% of your investment in 335 days.

Eclipsys Corporation is a healthcare information technology companydelivering solutions that enable healthcare providers to achieve improvedclinical, financial and administrative outcomes. Eclipsys offers an integrated suite of healthcare products in five critical areas -- clinical management, access management, patient financial management, strategic decision support and integration. Eclipsys' products have been designed to deliver a measurable impact on outcomes, enabling Eclipsys' customers to quantify clinical benefits and return on investment.

Auriga is committed to providing our clients with market information flow, investment ideas and access to industry experts. We strive to provide value through unique industry knowledge. Our growing research practice is being built with domain experts who have a strong reputation amongst institutional investors. Auriga’s research analysts have also been recognized by numerous industry publications including, The Wall Street Journal and Bloomberg. Our bottom-up fundamental approach is data point driven with a primary focus on growth sectors within the technology and healthcare verticals.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/23/2009 8:25 AM Buy
20.40 24.00
as of 12/31/2009
1 Week up  9.57 %
1 Month up  12.32 %
3 Months up  6.73 %
1 YTD up  0.98 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/25/2009 9:25 AM Hold
8.65 10.00
1/22/2009 8:25 AM Hold
8.13 12.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy